Upcoming Webinar Euro Infectious Diseases | Bacteriology Diseases 2020

Theme: Control and Treatment of Infection during Covid-19

Euro Infectious Diseases 2020

Renowned Speakers

Paul J Caesar
University Medical Center Groningen
Netherlands

Stef Stienstra
Royal Dutch Navy
Netherlands

Catherine Mullie
University of Lille
France

Anna Jinxia Zhang
University of Hong Kong
Hong Kong

Ines Garcia-Garcia
University of Puerto Rico
USA

Hasan Mujtaba
Xian Jiaotong University
China

Jason A Thompson
Emergency Products & Research Inc
USA

M Khalid Ijaz
City University of New York
USA

Leena Bhattacharya Mithal
Northwestern University
USA

Durgesh Sinha
Temple University
USA

Glenn S Tillotson
Cempra Pharmaceuticals
USA

Kartikeya Makker
University of Florida College of Medicine Jacksonville
USA

Francis J Castellino
University of Notre Dame
USA

Zharov Vladimir P
University of Arkansas for Medical Sciences
USA

Shantanu Bhatt
Saint Josephâ€™s University
USA

Marisa Egan
Saint Josephâ€™s University
USA

K C Santosh
University of South Dakota
USA

Eugenie Bergogne-Berezin
Universitaire Bichat-Claude Bernard
France

Guido Norbiato
University Hospital Luigi Sacco
Italy

Sofia Khalil
McGill University
Canada

Joanna Zajkowska
Medical University of BiaÅ‚ystok
Poland

Jilei Zhang
Yangzhou University
China

Amanuel Ateweberhan Woldemariam
Huazhong University of Science and Technology
China

Sion Jo
Chonbuk National University Hospital
South Korea

Adriana Macedo Dellâ€™Aquila
Federal University of Sao Paulo
Brazil

Lalit Garg
University of Malta
Malta

Anders Stockmarr
Echnical University of Denmark
Denmark

Anna Moniuszko Malinowska
Medical University of Bialystok
Poland

Maria Del Rosario DÃ¡valos Gamboa
University of San SimÃ³n
Bolivia

Peter Donald
Stellenbosch University
South Africa

Mona Abd El-fattah Ahmed
Ain-Shams University
Egypt

Chandrajit Lahiri
Sunway University
Malaysia

Shakuntala Mahilkar
National Institute of Virology
India

Soza Tharwat Mohammed Baban
University of Nottingham
UK

Yakubu Juliet M
Fatima Noman
Nigeria

Fatima Noman
Al-Iman General Hospital Riyadh
Pakistan

Janet Hammond
Roche Pharma Research and Early Development
Switzerland

Marcio J Pocas-Fonseca
University of Brasilia
Brazil

Euro Infectious Diseases 2020

We cordially invite you all the participants from all over the world to attend 12^th Euro-Global Conference on Infectious Diseases is going to be held during October 5-6, 2020 Webinar. The Conference highlights the theme “Control and Treatment of Infection during Covid-19".

Infectious Diseases are disorders caused by organisms such as bacteria, viruses, fungi, or parasites. Infectious diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of Microbiology especially Clinical and Diagnostic Microbiology which deals with the cure and prevention of the Infectious diseases. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health.

The conference attains significance when we look at the worldwide deaths due to Infectious Diseases. Tetanus (500,000), Measles (1 Million), HIV/AIDS (1 Million), Hepatitis B (1.1 Million), Malaria (2.1 Million), Diarrhoea(3.1Million), Tuberculosis (3.1 Million), Respiratory Infections (4.4 Million).

Who should attend?

Microbiologists
Bacteriologists
Virologists
Parasitologists
Mycologists
Pathologists
Pharmacists
Epidemiologists
Dermatologists
Neurologist
Ophthalmologist
Cardiologist
Health Care Professionals

Why to attend?

With members from around the world focused on learning about Control and Treatment of Infection during Covid-19 and its advances in therapeutic and diagnostic market, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World’s eminent speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

Targeted Audience

Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
Infectious Diseases Researchers, Scientists, Faculties, Students
Infectious Diseases Associations and Societies
Medical Colleges
Pharmaceutical Companies and Industries
Medical Devices Manufacturing Companies
Drug Manufacturing Companies and Industries
Laboratory Technicians and Diagnostic Companies
Business Entrepreneurs and Industrialists
Training Institutes
Software Developing Companies
Data Management Companies

Young Research’s Awards at Infectious Diseases 2020 Webinar

Infectious Diseases 2020 Webinar is intended to honor prestigious award for talented Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Gastroenterology.

Young Research’s Awards at Infectious Diseases 2020 Webinar for the Nomination:

Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation and only 25 presentations acceptable at the Infectious Diseases 2020 Webinar

YRF Registration benefits:

Young Scientist Award recognition certificate and memento to the winners
Infectious Diseases 2020 Webinar provides best Platform for your research through oral presentations.
Learn about career improvement with all the latest technologies by networking.
Provide an opportunity for research interaction and established senior investigators across the globe in the field of Infectious Diseases.
It is a great privilege for young researchers to learn about the research areas for expanding their research knowledge.

YRF Registration Deadline

Till July 30 – $399
Till August 30 – $499
Till September 28 – $599

Sessions/ Tracks

Viral Diseases

Virus is an obligate intracellular parasite that reproduces inside the cells of living hosts. Viral genome interacts with the host’s cellular gene to bring changes in phenotypes and its own evolution. Recent studies on Mimi virus and its Virophage lead to new discussions on the definition of virus. Virus can infect any body tissue from brain to skin.

Recommended Conferences:

12^th Euro-Global Conference on Infectious Diseases October 05-06, 2020 Webinar; 9^th Rare Diseases Conferences and Orphan Drugs Conferences, June 17-18, 2020 Berlin, Germany; 5^th Influenza Conferences and Zoonotic Diseases Meetings, June 17-18, 2020 Berlin, Germany; 12^th Euro-Global Conference on Infectious Diseases October 05-06, 2020 Webinar; 8^th Control and Prevention of HIV/AIDS, STDs Conferences & STIs Meeting, June 24-25 Rome Italy; Infectious Diseases Meetings, July 29-30, 2020 Amsterdam, Netherlands; 12^th Euro-Global Conference on Infectious Diseases October 05-06, 2020 Webinar; Clinical Microbiology Conferences, Virology Conferences and Infectious Diseases Conferences, November 19-20, 2018 Bucharest, Romania; 4^th Infectious Prevention Conferences, May 17-18, 2020 Philadelphia, USA; 12^th Euro-Global Conference on Infectious Diseases October 05-06, 2020 Webinar.

12^th International Conference on Epidemiology and Public Health September 23-24,2020 Berlin, Germany; 8^th Conference on Infectious Diseases & STD-AIDS, April 15-16 2020, Paris, France; 12^th Edition of International Conference on Infectious Diseases, April 22 -23, 2020, Rome, Italy; 3rd International Conference on Influenza and Emerging Infectious Diseases, April 10-11, 2020 Toronto, Ontario, Canada; 12^th World Congress on Virology and Infectious Diseases March 13-14, 2020 Singapore; Infectious Diseases Practice Updates 2020, Feb 04 - 08, 2020 , Waimea, Hawaii; International Conference on HIV/AIDS Prevention and Control, Feb 22, 2020 , Colombo, Sri Lanka; 2020 National HIV Prevention Conference, March 18 - 21, 2020 , Atlanta, Georgia; Immunization and Emerging Infections Expert Work Group March 18, 2020, Washington, DC; 25^th Annual Conference of the British HIV Association, April 02 - 05, 2020 , Bournemouth, England

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Europe: European Society for Clinical Microbiology and Infectious Diseases, British Society for Antimicrobial Chemotherapy, Society for General Microbiology, British Association for Sexual Health and HIV, British HIV Association, The Hospital Infection Society, Infection Prevention Society, British Society for Medical Mycology, The Royal Society of Tropical Medicine and Hygiene, Royal Society for Public Health.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Bacterial Diseases

Bacteria are prokaryotes which thrive in diverse environments. It contains DNA and lacks nucleus which reproduces by binary fission where it divides into 2 identical daughter cells. Some bacteria can form endospore which protects it from physical and chemical conditions. These organisms are classified according to their shape, by their cell walls or by differences in their genetic makeup. Antibiotics are used to treat bacterial infections. However recent studies shown that overuse or improper use of antibiotics developed several anti-biotic resistant bacteria.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Fungal Diseases

Fungus is a eukaryotic organism. They contain membrane-bound nuclei with chromosomes. The fungal infections range from superficial skin diseases to serious lung diseases. Few fungi are opportunistic: affects people with suppressed immune system and others are pathogenic: diseases causing fungi.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Emerging Diseases

Emerging Infectious Diseases are defined as severe outbreaks of previously unknown or undetected diseases or known diseases that have spread to new geographic location. HIV, Zika Virus, Dengue are few of the examples of emerging Diseases. Re-emerging Diseases are those infections whose incidence rate have been declined in the past but have reappeared. Malaria, Cholera, Tuberculosis are few re-emerging diseases.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Microbial Infections

The microbial pathogenesis and manipulation of immune defence has been a major threat to the human immune system. It can be minimised by conducting studies on the mechanism of how bacteria attack and survive in the host and important health hazards to be taken to prevent microbial infections.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Respiratory Diseases

Respiratory tract infection is further classified into upper respiratory tract infections and lower respiratory infections. LRT infections are any infections in the lungs or below the voice box whereas URT infections include the infections of sinuses, nasal passages, pharynx, and larynx.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Tropical Diseases

Tropical diseases are the infectious diseases that occur in the hot, humid conditions. Tropical regions of the world were more severely affected by infectious diseases in comparison to the rest of the world. Environmental and Biological factors play an important role in support of biodiversity of pathogens, vectors and hosts. Due to the interaction between tuberculosis and HIV epidemics, tuberculosis represents the leading cause of death in tropical regions.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Epidemiology of Diseases

Epidemiology of Diseases is defined as the study of incidence, prevalence and determinants of infections in the population. Study includes distribution rate and risk factors of infectious diseases. Evaluation of interventions can prevent development of diseases and disease associated deaths.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Dermatology and Infectious Diseases

Skin is the body’s largest organ which covers and protects the body from all type of infectious agents. Primary cutaneous infections or systemic infections with cutaneous manifestations are majorly caused by human papillomavirus, tinea, herpes, measles, varicella and impetigo. Diagnostic challenge and treatable nature of these infectious agents should be strongly considered to prevent advanced disease stage.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

HIV and AIDS

HIV attacks CD4 cells in the immune system and make copies of itself which gradually weakens the natural defence system of the body. AIDS is the advanced stage of HIV infection. It poses a greater risk in people with cancer and other life-threatening diseases. Human immunodeficiency virus spread through blood, semen, rectal fluids, breast milk and vaginal fluids.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Neurological Diseases

Neurological Diseases are diseases that affect brain, spine and the nerves connecting them. Neurological infections are caused when the viruses and infectious agents invade the nervous system. Brain is the direct target for certain bacterial, viral and parasitic infections. These pathogens reach the CNS either by blood stream or spread along peripheral nerves. Aseptic meningitis, acute flaccid paralysis, Encephalitis, Post infectious encephalon-myelitis is few infectious Neurological Disorders.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Obstetrics and Gynaecology

Postoperative infections are commonly seen in the obstetrics and gynaecology. These infections sometimes may be polymicrobial which means caused by several species of microorganisms. Early recognition and treatment can prevent a threat to the foetus.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Ophthalmology & Visual Sciences

Department of Ophthalmology and visual sciences deals with the study and treatment of various eye disorders in order to improve and maintain the vision. Early diagnosis and proper treatment of ocular infections is often required to avoid further complications. Toxoplasmosis retinochoroiditis and Herpes simplex virus keratouveitis, scleritis, and retinitis are serious eye diseases.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Paediatric Infectious Diseases

Paediatric infectious diseases are those occur in the children from birth to teen years. Two-third of the deaths of children in past 10 years was caused by infectious diseases. New-borns are at higher risk as their immune system is immature and cannot fight infections.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Pharmacology and Therapeutics

Pharmacology and Therapeutics is a source for advances in human therapeutics, transcends the drug discovery and development. It includes the study of pathophysiology of infectious diseases and mechanism of drug action, adverse drug effects, therapeutics and toxicology.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Immunology, Infection and Inflammatory Diseases

Immunology, Infection and Inflammatory Diseases deals with the principle components of the immune system, describing the molecules and cells that protect against infection and cancer. The study includes fundamental research, prototype discovery and design and effective pre-clinical trials.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Antibiotics

Antibiotics work by killing bacteria or inhibiting the growth of bacteria. They are not affective against viruses. Some classes of antibiotics are contraindicated in infants and children and extreme care should be taken while prescribing during pregnancy and lactation.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Vaccines

Vaccine is a biological preparation that supports immune system to fight particular diseases. It played a crucial role in saving lives and greatly changing the burden of many infectious diseases. Awareness and effectiveness of Vaccination has made many diseases rare over years.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Biomedical Engineering Techniques for Health Care

Biomedical engineering is a new approach in health technology assessment. It combines the design and problems solving skill of engineering with medical biological sciences to advance health care treatment.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Molecular Diagnosis of Infectious Diseases

Molecular Diagnostic Techniques developed a revolution in the diagnosing and monitoring pattern of infectious diseases. Advances in molecular diagnostic techniques over the past 10 years initiated new approach for microbial identification and characterization.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Prevention and Control

Infection prevention and control measures protect patients, staff and visitors from acquiring an infection and its transmission. Health care acquired infections are one of the biggest threat and most challenging factor which can be prevented by maintaining standard infection control precautions.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Public Health

Public health is the discipline which deals with the science and art of preventing infections by improving the health of population.

Recommended Conferences:

Related Societies and Associations:

USA: Infectious Disease Society of America, HIV Medicine Association, International Society for Infectious Diseases.

Asia Pacific: Human Genetics Society of Australasia, Genetics Society of Japan, NDC Medicine.

Market Analysis

Infections and Infectious diseases can be transmitted from animals to people or from one person to another. They can be mild and self-resolve or develop into serious illnesses if left untreated lead to serious illness, long-term consequences or death.

Two contrasting trends are apparent in the infectious disease market. On one hand, the market has witnessed unprecedented growth in the antiviral and vaccine areas since 2010. In particular, the antiviral market has doubled in size—from $20 billion in 2010 to $42 billion in 2017—driven by therapeutic paradigm shifts, especially in the hepatitis C market. On the other hand, there has been a continued decline in the market for systemic antibacterial therapies, with annual revenues dropping from $15 billion in 2010 to $8 billion in 2017, owing to generic competition and limited pipeline innovation. This trend has ultimately contributed to fuelling the political momentum and debate on antimicrobial resistance and raising the awareness on the need to incentivize innovation in antibiotic drug discovery and development.

With a compounded annual growth rate (CAGR) of 3% from 2017– 2022, the infectious disease market is forecast to expand, but more slowly than the overall prescription drug market, for which a CAGR of 6% is expected in the same period. The HIV integrase inhibitor-based class—the leading growth driver—is expected to generate $7.2 billion in additional sales in 2022 compared with 2017, fuelled by Gilead’s (Biktarvy and Genvoya) and GlaxoSmithKline’s (Triumeq) combination therapies. The polyvalent immunoglobulin segment (Shire’s Gammagard and CSL’s Privigen) and pneumococcal vaccines (Pfizer’s Prevnar 13 and Merck & Co.’s Pneumovax) are expected to be the second and third largest therapeutic areas, with 2022 sales of $9.5 billion and $8 billion, respectively.

The global infectious diseases therapeutics market size was valued at USD 46.88 billion in 2016 and is projected to grow at a CAGR of 6.6% during the forecast period. Rising prevalence and increasing expenditure of infectious ailments to boost the penetration rate of treatments of the diseases, rising initiatives for creating awareness about treatments & diagnosis of these conditions, and increasing clinical trial studies for development of new drugs are to be the factors responsible for growth of this market.

The global IVD infectious diseases market size was valued at USD 18.8 billion in 2018. It is likely to exhibit a CAGR of 6.7% from 2018 to 2026. Increasing external funding for research and development (R&D) activities and proactive government initiatives are among the primary growth stimulants for the market.

Based on the types of diseases, the market is segmented into HIV, malaria, hepatitis, influenza, Human Papillomavirus (HPV), and tuberculosis. In 2017, the Ebola segment held the largest share i.e., 49.8% of the market.

US is estimated to grow the rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to the infectious diseases. Current market trend shows that North America has the global market for infectious diseases therapeutics due to increasing incidence of infectious diseases due to rise in aging population. Followed by North America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. The main reasons behind the highest market of infectious diseases in the above countries are mainly due to large number of patients and due to increase in government funding.

Infectious Diseases Diagnostics Market:

Infectious disease molecular diagnostics tests include hospitals, blood banks, and reference laboratories. North America has the highest global market for molecular diagnostics followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Countries like Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years.

A closer look at the early and late-stage pipeline broadly confirms the key commercial trends in the market. Figure 3 clearly shows how vaccines and antivirals take the lion’s share of all the development activities: 71% of all the phase 1 and 2 compounds and 60% of all phase 3 assets in pipeline are in one of those two classes. Emerging BioSolutions’ NuThrax (anthrax vaccine) tops the list of the best-selling research and development (R&D) products in 2022, with a sell-side consensus forecast of $870 million according to Evaluate. However, pockets of R&D activities are emerging in the broad systemic antibacterial area and, on a smaller scale, for antimalarial therapies (Box 1).

Fig. 3 | Infectious diseases pipeline. a, Top ten therapy areas in the early-stage (phase 1–2) pipeline (841 candidates). b, Top ten therapy areas in the late-stage (phase 3) pipeline (206 candidates). The pipeline includes potential new molecular entities, new derivatives and potential candidates for new drug applications. Generics, biosimilars or over-the-counter products have not been accounted for. ImG, immunoglobulin G; Proto. Vx, protozoal vaccines; TB, tuberculosis.

Importance & Scope:

Infectious diseases are the second leading cause of world death rate, according to current estimates of the World Health Organization (WHO), the leading killers of children under five years of age. In spite of tremendous progress in Different Countries during the 20th century in reducing infectious disease deaths. When estimated, such deaths rank third behind cardiovascular disease and cancer in this country. With more than 1 billion people had crossed international borders in 2013. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2014. The largest market share taken by antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market. In 2015, 6.5 million individuals were infected with Human Immunodeficiency Virus (HIV) and 28% of the HIV infected people are using antiretroviral therapy. Moreover, increasing availability of targeted drugs is expected to pose significant threat to the market during the forecast period. Global infectious disease therapeutics market size valued at $ 46.88 billion in 2016 and is projected to grow at a CAGR of 6.6% during the forecast period. The Infectious disease diagnostic (IDD) market is estimated to grow at a CAGR of 7.9% to reach $18,156.2 million by 2019.

We live with a crowded and interconnected planet, with a projected global human population of at least 9 billion by 2050. The urbanization of the human population is at the risk of transmission of many infectious agents. Currently, >80% of humans live in developing countries, rising prevalence of infectious ailments, increasing expenditure to boost the penetration rate of treatments of these diseases, rising initiatives and creating awareness about treatments & diagnosis of these conditions, and increasing clinical trial studies for development of new drugs are likely to be the factors responsible for growth of this market. However, lack of awareness and treatments for these disorders and low adoption of treatments are factors to restraint the growth in the coming years.

Target Audience:

Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
Infectious Diseases Researchers, Scientists, Faculties, Students
Infectious Diseases Associations and Societies
Medical Colleges
Pharmaceutical Companies and Industries
Medical Devices Manufacturing Companies
Drug Manufacturing Companies and Industries
Laboratory Technicians and Diagnostic Companies
Business Entrepreneurs and Industrialists
Training Institutes
Microbiologists, Bacteriologists, Virologists
Parasitologists, Mycologists, Pathologists
Pharmacists, Epidemiologists, Dermatologists
Neurologist, Ophthalmologist, Cardiologist
Health Care Professionals
Academic Professionals
Medical & Pharmacy Companies

Related Companies/Industries:

GlaxoSmithKline (GSK)
Gilead Sciences
Merck & Co.
Pfizer
Sanofi
CSL
AbbVie
Shire
Grifols
Johnson & Johnson
Roche
AstraZeneca
BMS
Eli Lilly
Cubist
Astellas Pharma
AMGEN

Related Associations and Societies:

European Society of Clinical Microbiology and Infectious Diseases
International Union of Microbiological Societies
Federation of Infection Societies
Canadian Society of Microbiologists
British Infection Association
Federation of European Microbiological Societies
Welsh Microbiology Association
Clinical Virology Network
American Society for Microbiology
Society for General Microbiology
Infectious Diseases Society of America
International Society for Infectious Diseases
Clinical Infectious Diseases Society
National Institute of Allergy and Infectious Disease
Pediatric Infectious Diseases Society
Institute for global health and infectious diseases
International Union Against Tuberculosis and Lung Disease, Paris, France
Australasian Society for Infectious Diseases
European Society for Paediatric Infectious Diseases
Society of Infectious Diseases Pharmacists

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	October 5-6, 2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View